A series of 2,4-and 4,6-diaminopyrimidines were prepared and evaluated for their in vitro antimalarial activity. Of the 12 compounds tested 7 showed reasonable activity with 1 having a sub-micromolar IC50.
action of pyrimethamine is known to be inhibition of dihydrofolate reductase (DHFR), which prevents DNA biosynthesis leading to cell death [6] . Figure 1 . Known pyrimidine containing anti-malarial agents including drug pyrimethamine 3 [5, 6] The 2,4-and 4,6-diaminopyrimidine compounds were prepared via two sequential substitution reactions of dichloropyrimidine with substituted amines; an example reaction is outlined in Scheme 1 [7] . Using this biological data a preliminary structure-activity relationship (SAR) can be examined Fig. (2) .
The incorporation of cyclohexylamine instead of a substituted aniline [as in compounds (13) 
CONCLUSIONS
Seven compounds with antimalarial activity have been identified and utilized to develop a preliminary SAR. These compounds will be useful leads for further optimization in the quest to find new antimalarial agents. 
BIOLOGICAL TESTING
The parasite P. falciparum (K1, multidrug-resistant strain) was cultured continuously according to the method of Trager and Jensen [8] . Quantitative assessment of anti-plasmodial activity in vitro was undertaken by means of the microculture radioisotope technique based upon the method described by Desjardins et al [9] . Inhibition concentration (IC 50 ) represents the concentration which causes 50% reduction in parasite growth as indicated by the uptake of [ 3 H]-hypoxanthine by P. falciparum.
